Eversept Partners LP Invests $5.56 Million in Henry Schein, Inc. (NASDAQ:HSIC)

Eversept Partners LP acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 80,303 shares of the company's stock, valued at approximately $5,557,000. Eversept Partners LP owned 0.06% of Henry Schein at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of HSIC. J. Safra Sarasin Holding AG boosted its position in Henry Schein by 1.1% during the 4th quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock valued at $1,529,000 after buying an additional 231 shares during the period. State of Tennessee Department of Treasury increased its stake in shares of Henry Schein by 35.1% during the fourth quarter. State of Tennessee Department of Treasury now owns 137,817 shares of the company's stock valued at $9,537,000 after buying an additional 35,775 shares during the period. Van Lanschot Kempen Investment Management N.V. raised its holdings in shares of Henry Schein by 8.9% during the fourth quarter. Van Lanschot Kempen Investment Management N.V. now owns 823,828 shares of the company's stock valued at $57,009,000 after acquiring an additional 67,248 shares in the last quarter. Speece Thorson Capital Group Inc. boosted its stake in shares of Henry Schein by 0.4% during the 4th quarter. Speece Thorson Capital Group Inc. now owns 236,915 shares of the company's stock valued at $16,394,000 after purchasing an additional 948 shares in the last quarter. Finally, Natixis increased its position in shares of Henry Schein by 4.8% during the fourth quarter. Natixis now owns 695,250 shares of the company's stock valued at $48,111,000 after buying an additional 31,940 shares during the period. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Down 1.6 %

NASDAQ HSIC traded down $1.06 during mid-day trading on Friday, reaching $65.17. The stock had a trading volume of 736,945 shares, compared to its average volume of 1,619,866. The stock has a market cap of $7.98 billion, a PE ratio of 26.82, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a fifty day moving average price of $69.21 and a 200 day moving average price of $71.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.66 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on HSIC. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Finally, StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.